Compounds > n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine
Page last updated: 2024-09-03

n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and Abdominal Epilepsy

n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine has been researched along with Abdominal Epilepsy in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, BI; Markand, ON; Park, HM; Shen, W; Siddiqui, AR; Wellman, HH; Worth, RM1

Other Studies

1 other study(ies) available for n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and Abdominal Epilepsy

ArticleYear
HIPDM-SPECT brain imaging in the presurgical evaluation of patients with intractable seizures.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1990, Volume: 31, Issue:8

    Topics: Adolescent; Adult; Brain; Child; Epilepsies, Partial; Female; Humans; Iodobenzenes; Male; Temporal Lobe; Tomography, Emission-Computed, Single-Photon

1990